08/18/2025
1:50 PM | HCW Biologics (Filer)
| Form 8-K/A | |
08/18/2025
1:54 PM | HCW Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/15/2025
9:04 AM | HCW Biologics (Filer)
| Form NT 10-Q | |
08/14/2025
4:00 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2025
3:30 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
7:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2025
7:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2025
3:40 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
7:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
7:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
9:27 AM | HCW Biologics (Filer)
| Form 424B4 | |
Get the Latest News and Ratings for HCWB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter. |
05/14/2025
11:15 PM | HCW Biologics (Filer)
| Form EFFECT | |
05/13/2025
3:18 PM | HCW Biologics (Filer)
| Form S-1/A | |
05/09/2025
4:28 PM | Greene Rick S. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:29 PM | Flowers Lee (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:30 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:31 PM | GARRETT SCOTT T (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:32 PM | HCW Biologics (Issuer)
Wong Hing C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:33 PM | HCW Biologics (Issuer)
Winer Gary M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
12:55 PM | HCW Biologics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/28/2025
8:17 AM | HCW Biologics (Filer)
| Form DEF 14A | |
04/28/2025
7:45 AM | HCW Biologics (Filer)
| Form DEFA14A | |
04/28/2025
7:50 AM | HCW Biologics (Filer)
| Form ARS | |
04/22/2025
4:15 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2025
11:15 PM | HCW Biologics (Filer)
| Form EFFECT | |
04/16/2025
3:26 PM | HCW Biologics (Filer)
| Form 424B3 | |
04/07/2025
5:06 AM | HCW Biologics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/01/2025
3:40 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
3:30 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
2:40 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
2:45 PM | HCW Biologics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2025
4:00 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:25 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:29 PM | HCW Biologics (Filer)
| Form DEF 14A | |
02/11/2025
3:54 PM | HCW Biologics (Filer)
| Form PRE 14A | |
02/07/2025
3:45 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
6:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
7:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:37 PM | HCW Biologics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/22/2024
3:53 PM | HCW Biologics (Subject)
Wong Hing C (Filed by)
| Form SC 13D/A | |
Overnight moves = possibly bigger returns (Ad) Here’s a chart everyone should see that dates back to 1993…
As you can see, the top line shows the much bigger average market return from trading overnight…
Versus the bottom line, which shows the more modest average return from trading during the day.
Look at that gigantic difference!
So if you prefer nice big overnight returns instead, I agree with you.
That’s why I’ve designed a breakthrough trade to tap into that overnight trading frenzy.
You can check that out right here.
Obviously, I won’t make any reckless guarantees in the stock market, but…
That eye-opening chart above is just the beginning of the benefits you’ll see to trading overnight.
PLUS, you’ll also see what my #1 ranked asset is in the entire market…
And what my “hands-off” stocks are that I wouldn’t touch with a 100-foot pole. Check out the breakthrough overnight trade before I take the video down. |
11/22/2024
3:45 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
11:54 AM | HCW Biologics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
11/18/2024
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
4:25 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access